Stryker Corp (SYK, Financial) has recently captured the attention of investors and financial analysts with its strong financial performance. Currently trading at $389.4 per share, Stryker Corp has experienced a slight daily decrease of 0.17%, yet it boasts a significant three-month gain of 15.5%. A detailed evaluation using the GF Score indicates that Stryker Corp is poised for substantial future growth.
What Is the GF Score?
The GF Score is a proprietary stock performance ranking system developed by GuruFocus. It evaluates stocks based on five key aspects: financial strength, profitability, growth, GF Value, and momentum. These components are weighted differently to calculate a comprehensive score ranging from 0 to 100, with 100 indicating the highest potential for outperformance. Stryker Corp has achieved an impressive GF Score of 94, signaling strong future returns.
- Financial strength rank: 6/10
- Profitability rank: 9/10
- Growth rank: 10/10
- GF Value rank: 5/10
- Momentum rank: 10/10
Understanding Stryker Corp's Business
Stryker Corp designs, manufactures, and markets a diverse range of medical technologies, including orthopedic implants and surgical equipment. With a market cap of $148.45 billion and annual sales of $21.97 billion, the company demonstrates a robust operating margin of 19.95%. Stryker is a leading player in the medical devices sector, particularly known for its innovations in orthopedic implants and operating room equipment. Approximately 25% of its revenue is generated from international markets.
Financial Strength and Stability
Stryker Corp's financial resilience is reflected in its Financial Strength rating and an Altman Z-Score of 5.36, indicating low risk of financial distress. The company's strategic debt management is evident from its favorable Debt-to-Revenue ratio of 0.71, underscoring its financial health.
Profitability and Growth Metrics
Stryker Corp's Profitability Rank is outstanding, supported by a high Piotroski F-Score and a Predictability Rank of 5 stars, reflecting consistent operational performance. The company's commitment to growth is evident from its 12.3% three-year revenue growth rate and significant EBITDA increases, outperforming 62.84% of its industry peers.
Conclusion
Considering Stryker Corp's robust financial strength, impressive profitability, and sustained growth metrics, the GF Score highlights the company's strong position for potential market outperformance. Investors looking for similar opportunities can explore other high-scoring companies using the GF Score Screen.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
